businesspress24.com - Horizon Pharma to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2012 Fina
 

Horizon Pharma to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2012 Financial Results on March 18, 2013

ID: 1202823

(firmenpresse) - DEERFIELD, IL -- (Marketwire) -- 03/04/13 -- Horizon Pharma, Inc. (NASDAQ: HZNP) announced today that its fourth quarter and year ended December 31, 2012 financial results will be released on Monday, March 18, 2013. Following the announcement, Horizon's management will host a live conference call and webcast at 8:00 am Eastern Time to review the Company's financial and operating results and provide a general business update.

The live webcast and a replay may be accessed by visiting Horizon's website at . Please connect to the Company's website at least 15 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. Alternatively, please call 1-888-338-8373 (U.S.) or 973-872-3000 (international) to listen to the conference call. The conference ID number for the live call is 11959520. Telephone replay will be available approximately two hours after the call. To access the replay, please call 1-855-859-2056 (U.S.) or 404-537-3406 (international). The conference ID number for the replay is 11959520.

Horizon Pharma, Inc. is a specialty pharmaceutical company that has developed and is commercializing DUEXIS and RAYOS/LODOTRA, both of which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The Company's strategy is to develop, acquire, in-license and/or co-promote additional innovative medicines where it can execute a targeted commercial approach in specific therapeutic areas while taking advantage of its commercial strengths and the infrastructure the Company has put in place. For more information, please visit .



Robert J. De Vaere
Executive Vice President and Chief Financial Officer


Investors
Kathy Galante
Burns McClellan, Inc.
212-213-0006




Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Cellceutix Signs With Leading Cancer Center for Licensing New Drug
Immunovative Inc. Files for Name and Symbol Change; After Necessary Approvals, Company Will Be Called: Tauriga Sciences, Inc.
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 04.03.2013 - 06:30 Uhr
Sprache: Deutsch
News-ID 1202823
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

DEERFIELD, IL


Phone:

Kategorie:

Biotech


Anmerkungen:


Diese Pressemitteilung wurde bisher 92 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Horizon Pharma to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2012 Financial Results on March 18, 2013
"
steht unter der journalistisch-redaktionellen Verantwortung von

Horizon Pharma (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Horizon Pharma



 

Who is online

All members: 10 566
Register today: 1
Register yesterday: 0
Members online: 0
Guests online: 107


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.